CN108938912B - 防治阵发性房颤的中药组合物及其超微粉水丸剂和应用 - Google Patents
防治阵发性房颤的中药组合物及其超微粉水丸剂和应用 Download PDFInfo
- Publication number
- CN108938912B CN108938912B CN201810822906.XA CN201810822906A CN108938912B CN 108938912 B CN108938912 B CN 108938912B CN 201810822906 A CN201810822906 A CN 201810822906A CN 108938912 B CN108938912 B CN 108938912B
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- traditional chinese
- chinese medicine
- atrial fibrillation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 81
- 239000000843 powder Substances 0.000 title claims abstract description 61
- 239000006187 pill Substances 0.000 title claims abstract description 50
- 206010003658 Atrial Fibrillation Diseases 0.000 title claims abstract description 40
- 239000000203 mixture Substances 0.000 title claims abstract description 18
- 239000000463 material Substances 0.000 claims description 20
- 238000002360 preparation method Methods 0.000 claims description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 240000000249 Morus alba Species 0.000 claims description 15
- 235000008708 Morus alba Nutrition 0.000 claims description 15
- 229940079593 drug Drugs 0.000 claims description 13
- 241000227129 Aconitum Species 0.000 claims description 12
- 244000037364 Cinnamomum aromaticum Species 0.000 claims description 10
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims description 10
- 241000270666 Testudines Species 0.000 claims description 10
- 210000000582 semen Anatomy 0.000 claims description 10
- 241000237502 Ostreidae Species 0.000 claims description 9
- 241000270708 Testudinidae Species 0.000 claims description 9
- 210000003608 fece Anatomy 0.000 claims description 9
- 235000020636 oyster Nutrition 0.000 claims description 9
- 244000306301 Caesalpinia sappan Species 0.000 claims description 8
- 235000015162 Caesalpinia sappan Nutrition 0.000 claims description 8
- 244000020518 Carthamus tinctorius Species 0.000 claims description 8
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims description 8
- 241000545744 Hirudinea Species 0.000 claims description 8
- 241000208682 Liquidambar Species 0.000 claims description 8
- 235000006552 Liquidambar styraciflua Nutrition 0.000 claims description 8
- 244000290970 Tetrapanax papyrifer Species 0.000 claims description 8
- 235000013399 edible fruits Nutrition 0.000 claims description 8
- 241000254173 Coleoptera Species 0.000 claims description 7
- 240000005373 Panax quinquefolius Species 0.000 claims description 7
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 7
- 235000008331 Pinus X rigitaeda Nutrition 0.000 claims description 7
- 235000011613 Pinus brutia Nutrition 0.000 claims description 7
- 241000018646 Pinus brutia Species 0.000 claims description 7
- 240000006079 Schisandra chinensis Species 0.000 claims description 7
- 235000008422 Schisandra chinensis Nutrition 0.000 claims description 7
- 241000037740 Coptis chinensis Species 0.000 claims description 5
- 241000628997 Flos Species 0.000 claims description 5
- 241000237903 Hirudo Species 0.000 claims description 5
- 241000606266 Nardostachys Species 0.000 claims description 5
- 241000208966 Polygala Species 0.000 claims description 5
- 240000004534 Scutellaria baicalensis Species 0.000 claims description 5
- 235000017089 Scutellaria baicalensis Nutrition 0.000 claims description 5
- 229920002472 Starch Polymers 0.000 claims description 5
- 244000126002 Ziziphus vulgaris Species 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 238000010298 pulverizing process Methods 0.000 claims description 5
- 235000019698 starch Nutrition 0.000 claims description 5
- 239000008107 starch Substances 0.000 claims description 5
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 claims description 4
- 239000002994 raw material Substances 0.000 claims description 4
- 229940126680 traditional chinese medicines Drugs 0.000 claims description 4
- 241000096284 Gynochthodes officinalis Species 0.000 claims description 2
- 241001080798 Polygala tenuifolia Species 0.000 claims description 2
- 240000007641 Spergula rubra Species 0.000 claims description 2
- 238000009472 formulation Methods 0.000 claims description 2
- 230000002265 prevention Effects 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 41
- 208000024891 symptom Diseases 0.000 abstract description 24
- 206010033557 Palpitations Diseases 0.000 abstract description 16
- 206010003119 arrhythmia Diseases 0.000 abstract description 15
- 230000006793 arrhythmia Effects 0.000 abstract description 15
- 230000007812 deficiency Effects 0.000 abstract description 14
- 238000007667 floating Methods 0.000 abstract description 10
- 208000000059 Dyspnea Diseases 0.000 abstract description 3
- 206010013975 Dyspnoeas Diseases 0.000 abstract description 3
- 208000013220 shortness of breath Diseases 0.000 abstract description 3
- 230000007012 clinical effect Effects 0.000 abstract 1
- 210000003734 kidney Anatomy 0.000 description 17
- 210000002216 heart Anatomy 0.000 description 15
- 238000011160 research Methods 0.000 description 14
- 238000000034 method Methods 0.000 description 13
- 241001247821 Ziziphus Species 0.000 description 12
- 208000011580 syndromic disease Diseases 0.000 description 12
- 206010037660 Pyrexia Diseases 0.000 description 10
- 230000001976 improved effect Effects 0.000 description 9
- 230000002936 tranquilizing effect Effects 0.000 description 8
- 206010008479 Chest Pain Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 210000004185 liver Anatomy 0.000 description 7
- 210000005036 nerve Anatomy 0.000 description 7
- 230000002829 reductive effect Effects 0.000 description 7
- 230000002159 abnormal effect Effects 0.000 description 6
- 230000008901 benefit Effects 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 230000002107 myocardial effect Effects 0.000 description 6
- 230000000144 pharmacologic effect Effects 0.000 description 6
- 239000004480 active ingredient Substances 0.000 description 5
- IYIKLHRQXLHMJQ-UHFFFAOYSA-N amiodarone Chemical compound CCCCC=1OC2=CC=CC=C2C=1C(=O)C1=CC(I)=C(OCCN(CC)CC)C(I)=C1 IYIKLHRQXLHMJQ-UHFFFAOYSA-N 0.000 description 5
- 229960005260 amiodarone Drugs 0.000 description 5
- 208000002173 dizziness Diseases 0.000 description 5
- 210000003127 knee Anatomy 0.000 description 5
- 206010029446 nocturia Diseases 0.000 description 5
- 230000035807 sensation Effects 0.000 description 5
- 235000019615 sensations Nutrition 0.000 description 5
- 238000010792 warming Methods 0.000 description 5
- 206010013954 Dysphoria Diseases 0.000 description 4
- 210000000467 autonomic pathway Anatomy 0.000 description 4
- 210000000170 cell membrane Anatomy 0.000 description 4
- 230000000857 drug effect Effects 0.000 description 4
- 210000003414 extremity Anatomy 0.000 description 4
- 230000001939 inductive effect Effects 0.000 description 4
- 102000004310 Ion Channels Human genes 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000003213 activating effect Effects 0.000 description 3
- 239000002671 adjuvant Substances 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 230000013872 defecation Effects 0.000 description 3
- 230000002950 deficient Effects 0.000 description 3
- 238000004090 dissolution Methods 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 235000008216 herbs Nutrition 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 230000002889 sympathetic effect Effects 0.000 description 3
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 2
- 229930182837 (R)-adrenaline Natural products 0.000 description 2
- WZRCQWQRFZITDX-UHFFFAOYSA-N (RS)-norcoclaurine Chemical compound C1=CC(O)=CC=C1CC1C2=CC(O)=C(O)C=C2CCN1 WZRCQWQRFZITDX-UHFFFAOYSA-N 0.000 description 2
- 206010063659 Aversion Diseases 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- WZRCQWQRFZITDX-AWEZNQCLSA-N Norcoclaurine Natural products C1=CC(O)=CC=C1C[C@H]1C2=CC(O)=C(O)C=C2CCN1 WZRCQWQRFZITDX-AWEZNQCLSA-N 0.000 description 2
- 244000248557 Ophiopogon japonicus Species 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 206010057040 Temperature intolerance Diseases 0.000 description 2
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 2
- 229960004373 acetylcholine Drugs 0.000 description 2
- 102000012740 beta Adrenergic Receptors Human genes 0.000 description 2
- 108010079452 beta Adrenergic Receptors Proteins 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 230000009189 diving Effects 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 239000003792 electrolyte Substances 0.000 description 2
- 230000002124 endocrine Effects 0.000 description 2
- 229960005139 epinephrine Drugs 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 230000002964 excitative effect Effects 0.000 description 2
- 230000007717 exclusion Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 230000013632 homeostatic process Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 230000001788 irregular Effects 0.000 description 2
- 230000003907 kidney function Effects 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 206010029410 night sweats Diseases 0.000 description 2
- 230000036565 night sweats Effects 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 238000002203 pretreatment Methods 0.000 description 2
- 230000033764 rhythmic process Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 210000004243 sweat Anatomy 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 210000001186 vagus nerve Anatomy 0.000 description 2
- 208000003663 ventricular fibrillation Diseases 0.000 description 2
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N (E)-cinnamaldehyde Chemical compound O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 description 1
- LQIAZOCLNBBZQK-UHFFFAOYSA-N 1-(1,2-Diphosphanylethyl)pyrrolidin-2-one Chemical compound PCC(P)N1CCCC1=O LQIAZOCLNBBZQK-UHFFFAOYSA-N 0.000 description 1
- 241000173529 Aconitum napellus Species 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 241000748223 Alisma Species 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 241000218202 Coptis Species 0.000 description 1
- 235000002991 Coptis groenlandica Nutrition 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 208000000857 Hepatic Insufficiency Diseases 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229930195210 Ophiopogon Natural products 0.000 description 1
- 244000046146 Pueraria lobata Species 0.000 description 1
- 235000010575 Pueraria lobata Nutrition 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 241000207929 Scutellaria Species 0.000 description 1
- 238000000692 Student's t-test Methods 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 206010049447 Tachyarrhythmia Diseases 0.000 description 1
- 208000001871 Tachycardia Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- 235000006545 Ziziphus mauritiana Nutrition 0.000 description 1
- 240000008866 Ziziphus nummularia Species 0.000 description 1
- 235000008529 Ziziphus vulgaris Nutrition 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 229940023019 aconite Drugs 0.000 description 1
- 230000036982 action potential Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000003288 anthiarrhythmic effect Effects 0.000 description 1
- 239000003416 antiarrhythmic agent Substances 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 230000003177 cardiotonic effect Effects 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 229940117916 cinnamic aldehyde Drugs 0.000 description 1
- KJPRLNWUNMBNBZ-UHFFFAOYSA-N cinnamic aldehyde Natural products O=CC=CC1=CC=CC=C1 KJPRLNWUNMBNBZ-UHFFFAOYSA-N 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000002565 electrocardiography Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 230000000622 irritating effect Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 238000001543 one-way ANOVA Methods 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000004031 partial agonist Substances 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 238000009666 routine test Methods 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000006016 thyroid dysfunction Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000002861 ventricular Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000009278 visceral effect Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/714—Aconitum (monkshood)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
- A61K35/10—Peat; Amber; Turf; Humus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/586—Turtles; Tortoises, e.g. terrapins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/36—Caryophyllaceae (Pink family), e.g. babysbreath or soapwort
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/59—Menispermaceae (Moonseed family), e.g. hyperbaena or coralbead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/69—Polygalaceae (Milkwort family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/718—Coptis (goldthread)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/746—Morinda
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/79—Schisandraceae (Schisandra family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/84—Valerianaceae (Valerian family), e.g. valerian
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/884—Alismataceae (Water-plantain family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8968—Ophiopogon (Lilyturf)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Marine Sciences & Fisheries (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Tropical Medicine & Parasitology (AREA)
- Insects & Arthropods (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明公开了一种防治阵发性房颤的中药组合物及其超微粉水丸剂和应用,该药物是由附子、桂枝、生牡蛎、泽泻、地骨皮、磁石、防己、路路通、炙远志、桑白皮、苏木、琥珀粉、麦冬、桑枝、葛根、通草、鳖甲、蜣螂、松子、生龙骨、龟板、甘松、炒枣仁、生枣仁、水蛭、红花、黄连、黄芩、西洋参、五味子、巴戟天、银柴胡、生地制成超微粉水丸剂。本发明用于防治心律失常符合中医阴阳两虚、虚阳上浮证型,主要针对房颤患者以及各种心律失常见心悸、气短、畏寒等,疗效显著、临床效果好,制成的超微粉水丸剂体积小,便于服用和携带。
Description
技术领域
本发明涉及一种治疗心率失常疾病的中药组合物和新剂型,尤其是一种防治阵发性房颤的中药组合物及其超微粉水丸剂和应用,属于中药技术领域。
背景技术
房颤是临床最常见的心律失常之一,中国已经达到 600万人,随着人口老龄化,预测将来会增加更多病例。目前房颤的治疗方法包括药物治疗和非药物治疗,由于经济原因和房颤 射频术后复发等因素,药物治疗仍是治疗房颤的重要手段。随着科学技术进步,中医药在预防和防治阵发性房颤中起到越来越重要的作用,具体优势体现在毒副反应小、疗效显著等,但现有的防治阵发性房颤的中成药普遍存在药效作用不显著、疗效不够迅速、药材资源浪费严重的缺点,使得其在市场上应用有一定局限性。因此,研制和开发出疗效迅速、有效成份明显的中药制剂已越来越受到人们的重视。
发明内容
本发明要解决的技术问题在于提供一种防治阵发性房颤的中药组合物及超微粉水丸新剂型,从而提高药物疗效和药材利用率。
为解决上述技术问题,本发明采用的技术方案如下:
防治阵发性房颤的中药组合物,按重量份计算,该中药组合物由以下重量份的原料药制成:附子5-7份、桂枝9-11份、生牡蛎20-30份、泽泻10-20份、地骨皮20-30份、磁石20-40份、防己10-30份、路路通10-30份、炙远志10-20份、桑白皮10-30份、苏木5-7份、琥珀粉5-7份、麦冬10-20份、桑枝9-11份、葛根10-20份、通草10-30份、鳖甲10-30份、蜣螂9-11份、松子10-15份、生龙骨10-30份、龟板10-30份、甘松9-11份、炒枣仁10-20份、生枣仁 10-20份、水蛭5-7份、红花5-7份、黄连2-4份、黄芩10-15份、西洋参5-7份、五味子5-7份、巴戟天6-8份、银柴胡10-30份、生地10-20份。
上述的防治阵发性房颤的中药组合物中,所述原料的优选重量为:附子6g、桂枝10g、生牡蛎25g、泽泻15g、地骨皮25g、磁石30g、防己20g、路路通20g、炙远志15g、桑白皮20g、苏木 6g、琥珀粉6g、麦冬15g、桑枝10g、葛根15g、通草20g、鳖甲20g、蜣螂 10g、松子12g、生龙骨25g、龟板20g、甘松10g、炒枣仁15g、生枣仁 15g、水蛭6g、红花6g、黄连3g、黄芩12g、西洋参 6g、五味子6g、巴戟天7g、银柴胡25g、生地15g。
上述的防治阵发性房颤的中药组合物在制备防治阵发性房颤药物中的应用。
上述的防治阵发性房颤的中药组合物制备的剂型,它是由前述的中药组合物和药学上可接受的载体组成,所述剂型可以是颗粒剂、片剂、胶囊剂、丸剂或超微粉水丸剂。
上述的防治阵发性房颤的中药组合物制备的超微粉水丸剂,按照以下工艺步骤制得,
(1)将中药材附子、桂枝、生牡蛎、泽泻、地骨皮、磁石、防己、路路通、炙远志、桑白皮、苏木、琥珀粉、麦冬、桑枝、葛根、通草、鳖甲、蜣螂、松子、生龙骨、龟板、甘松、炒枣仁、生枣仁、水蛭、红花、黄连、黄芩、西洋参、五味子、巴戟天、银柴胡、生地,在温度20℃以下利用中药超微粉碎机粉碎为超微粉,细度为250-350目;
(2)将打成超微粉的上述中药材按照处方剂量等比例混合,利用全自动中药水丸机加入处方量1%-5%的辅料淀粉和水,制成水丸即得到超微粉水丸剂。
超微粉水丸剂在制备防治阵发性房颤药物中的应用。
本发明的有益效果:本发明的药物具有温补心肾、滋阴潜阳、调和阴阳的功效,用于防治心律失常符合中医阴阳两虚、虚阳上浮证型,主要针对房颤(包括阵发性房颤和持续性房颤)患者以及各种心律失常见心悸、气短、畏寒等。
本发明的组方理念核心在于温潜法。方中制附子始载于《神农本草经》,辛、甘、大热,归心、肾、脾经,用以温补肾阳、引火归原,正如《别录》曰:“可升可降,阳中之阴,浮中沉,无所不至,为诸经引用之药”,现代药理学研究表明,附子具有强心的作用,其主要成分去甲乌药碱是β受体部分激动剂,其强心作用与兴奋β受体有关,同时附子还有抗心律失常作用,去甲乌药碱能改善房室传导,加快心率,恢复窦性心律。现代药理研究还发现附子可以增加心肌营养性血流量,对心肌具有保护作用。桂枝辛散温通,具有温通心阳,补肾阳,止悸动的作用,与附子联用温肾助阳,补命门之火,共同治疗本证中的肾阳不足所致的阳虚之火外浮。现代药理学研究表明,桂枝中主要成分肉桂醛具有扩张血管,改善心肌供养及抗心律失常的作用。方中龙骨、牡蛎伍用,益阴潜阳,镇静安神,龙骨益阴之中能潜上越之浮阳,牡蛎益阴之中能摄下陷之沉阳。现代研究表明,龙骨可以减少实验小鼠的自主活动,具有镇静、催眠的作用,同时与牡蛎合用可以抑制交感神经兴奋。桂枝龙骨牡蛎这三药同用,遵仲景之法,补阳宁心,镇静安神。龟板鳖甲合用滋阴潜阳,龟板滋养肾阴,鳖甲滋养肝阴。肝肾同源,两者合用同补肝肾,滋阴补虚,调理脏腑功能失调。磁石辛咸微温,归肾经,具有潜阳镇惊的功效,如《本草汇言》所言:“肾为水藏,磁石色黑而法水,故能养肾而强骨益髓”。琥珀性甘平,具有宁心复脉, 活血利水的功效,同时现代药理研究琥珀抗快速心律失常作用。本方中较大量的使用用重镇安神类药物,现代研究证实,镇静安神类药物具有调节自主神经功能作用。实验表明,该类药物可以直接作用于离体或切断神经的心脏,对多种心律失常有显著抑制作用,亦可通过维持交感、迷走神经内分泌稳态,减少肾上腺素异常分泌,增加乙酰胆碱含量,降低自主神经异常对心肌细胞膜离子通道影响。现代药理学研究甘松具有抗心律失常的作用,其有效成分为缬卓酮具有膜抑制及延长动作电位作用,其作用可能与阻滞多种细胞膜离子通道相关。虚阳之火上扰神明,故见头晕,五心烦热不得眠,炙远志、酸枣仁合用取其养心安神、交通心肾之功,配合本方中重镇安神类药物共同潜外浮之虚阳。《本草纲目》言:“酸枣仁,甘而润,故熟用疗胆虚不得眠,烦渴虚汗之证。”同时现代研究也证实,酸枣仁对多种实验性心律失常均有明显作用。取泽泻、路路通、桑枝、通草等通经活络,利尿除湿之功,辅以交通心肾,调节脏腑功能平衡,现代研究其也有抗心肌重塑、利尿、降血压等作用。小剂量予水蛭,红花,苏木等活血通络药物,通达三焦。本方所对证之病人,以阴阳两虚为本,同时也有虚阳上浮的证候,故少量予黄芩、黄连之寒助以重镇安神药物降外浮之阳。动物实验也证明,黄连主要成分黄芩茎叶总黄酮可明显缩短实验小鼠室速,降低室颤的发生率。诸药合用以行温通阳气、滋阴复脉、降火潜阳、安神镇静之功。
本发明的超微粉水丸剂是一种全新的药物剂型,具有以下特点:
(1)单位制剂的活性物质含量更高、药效更显著,对药材有效成分的提取更加完全,主要药效物质的含量明显提高,能够使制剂更好地发挥药效,同时可以节约中药资源。因为普通中药粉中的有效成份释放需要通过细胞膜,所以在直接内服或采用传统水煎或醇提法提取药物时,有许多有效成份未能被利用,造成浪费。本发明的超微粉水丸剂使药材粒度达到细胞破碎级,使药物细胞间和细胞内有效成分直接释放出来,提高了药物中有效成分的溶出速度和溶出率。
(2)增加药物的吸收率,提高生物利用度。药物的溶出速度一般与药物颗粒比表面积呈正比,而比表面积与粒径呈反比。本发明的超微粉水丸剂增大了药材的比表面积,与胃肠黏膜的接触面积变大,附着力增强,使药物在消化道内停留时间长,使药物吸收更充分,从而提高了药物的生物利用度。
(3)提高药效,减少用药剂量,节约原料药材。药材经超微粉碎后,粒度变得更细小,有效成分更易于溶出,药效也相应增强,药材利用率高,从而减少用药剂量,大大节约原料药材。
(4)服用方便,煎煮服即可,可提高患者医从性。
(5)丸剂煎煮服,较常规服药减少了药物的微生物污染。
本发明先加工成超微粉,接着泛水丸,比胶囊的毒性小,比软胶囊的药材利用率高,比单纯散剂好服用,比普通水丸易于崩解吸收,可直接吞服,也可开水冲服,用水煮开更好,相当于古代的煮散,节省药材,再者药物经超微粉处理后水煎服可以杀灭药物里的微生物,比传统药物更清洁、高效,同时超微粉又是现代的前沿技术,制成的超微粉水丸剂体积小,便于服用和携带。
本发明药物经临床检验,取得了很好的疗效,总结如下:
1 临床资料
1.1 西医诊断标准
参照《黄宛临床心电图学》标准拟定。①心电图表现:P波消失;心室颤动(QRS波)频率完全不规则;在各导联中基线为不规则低振幅的快速摆动和颤动波,系大小不同、形态各异、间隔不均匀的AF波,其频率为350~600次/分。②体征:第一心音强度不等,心律绝对不齐,脉搏短绌。
1.2中医诊断标准
房颤属中医“心悸病”,参考《中药新药临床研究指导原则》和第6版《中医内科学》中医诊断分型标准,拟定心悸阴阳两虚、虚阳上浮证型的诊断标准。主症:心悸,气短,畏寒肢冷,五心烦热;次症:胸闷,头晕,潮热盗汗,自汗,腰膝酸软,大便干,夜尿频数,舌红,少苔,脉细数结代。
1.3纳入和排除标准
纳入标准:心电图检查符合房颤诊断,且病程至少2个月,发作频率至少每月2次,每次持续时间不超过24h;阵发性房颤经休息或治疗可转复为窦性心律;未服用相关抗心律失常药物或已停药至少5个半衰期;年龄50~80岁;中医辨证分型属阴阳两虚、虚阳上浮证型。本研究经医院伦理委员会审查并批准,取得患者同意,并签署知情同意书。
排除标准:妊娠或哺乳期妇女;对碘或胺碘酮过敏者;甲状腺功能异常;严重心功能不全患者;严重肝、肾功能不全者。
1.4一般资料
所选病例均是申请人门诊患者,病例总人数共80人,随机分为对照组和治疗组,每组40例,对照组男21例,女19例,年龄在53~79岁不等,平均年龄68岁,病程2个月到2年;治疗组男22例,女18例,年龄在55岁~76岁不等,平均年龄65.5岁,病程3个月到4年,2组在年龄、性别、病程上经过统计学计算,无统计学差异,具有可比性。
1.5 药物制备 本发明超微粉水丸由贵州苗立克中药科技有限公司制备,0.5g /丸。胺碘酮生产企业为上海信宜药厂有限公司(批准文号:国药准字H31021872),0.2g /片。
2 方法
2.1治疗方法
两组病人对基础疾病及抗凝治疗保持一致,对照组给予口服胺碘酮,第1周0.2g每日3次;第2周0.2g,每日2次;第3周起至疗程结束0.2g,每日1次。治疗组给予口服胺碘酮(第1周0.2g每日3次;第2周0.2g,每日2次;第3周0.2g,每日1次;第四周起至疗程结束0.2g,隔日一次)联合本发明超微粉水丸,每日三次,每次10丸,分三次煎煮服用。2组均以30天为一疗程,共治疗5个疗程。
2.2 观察指标
两组患者分别于用药后第4周至少每周检查一次常规心电图或24h动态心电图,第8周后至少每两周检查一次常规心电图或24h动态心电图,直至研究结束。同时记录患者心率、血压等,如发现心律失常,立即行常规心电图或24h动态心电图检查,直至研究结束。另外在服药期间行智能可穿戴无线微型心电监测仪监测,有症状出现时立即监测,记录房颤发作次数,直到研究结束。服药期间,平均每月一次血、尿、便常规及电解质、肝、肾功能,胸片等检查, 以判定疗效及药物不良反应;
2.3 疗效标准
参照《中药新药临床研究指导原则》制定。显效:心悸症状消失,心电图或动态心电图明显改善,心房颤动发作基本控制或频发转为偶发;有效:心悸症状大部分消失,心电图或动态心电图有所改善,房颤发作较治疗前减少50%以上,持续时间较治疗前缩短50%以上,或频发转为多发,或多发转为偶发;无效:心悸症状和心电图或动态心电图无变化或加重。
2.4中医证候疗效评定标准
参照《中药新药临床研究指导原则》(试行),根据中医症状积分变化进行评定。积分变化%=(治疗前积分-治疗后积分)/治疗前积分×100%。显效:临床症状、体征明显改善,症状积分减少≥70%。有效:临床症状、体征均有好转,症状积分减少≥50%。无效:临床症状、体征无明显改善,症状积分减少不足30%。
2.5中医证候评分标准
参照《中药新药临床研究指导原则》中证候计量方法,将症状分为4级,即正常、轻度异常、中度异常、重度异常,根据证候总计分,建立轻、中、重的分级诊断标准。其中主症中无心悸计0分,偶有轻微心悸计2分,心悸阵法计4分,心悸怔忡计6分;无气短计0分,一般活动后气短计2分,稍活动后气短计4分,动则气短计6分;无畏寒肢冷计0分,轻度畏寒计2分,四肢发冷计4分,全身发冷,得温不解计6分;无五心烦热计0分,晚间手足心热计2分,心烦手足心灼热计4分,烦热不欲衣被计6分。次症中午胸闷计0分,偶有胸闷,胸闷轻微计1分,阵发胸闷,胸闷明显计2分,胸闷如窒,不能平卧,影响活动计3分;无头晕计0分,头晕轻微,偶尔发生,不影响正常活动及工作计1分,头晕较重,活动时出现,休息后缓解计2分,头晕重,视物旋转,行走欲扑,持续不缓解计3分;无潮热盗汗计0分,偶有头部潮热汗出计1分,脚背潮热、潮湿,反复出现计2分,周身潮热,经常出现计3分;无自汗计0分,平素皮肤微潮计1分,稍动汗出计2分,动辄汗出计3分;无腰膝酸软计0分,晨起腰酸,捶打可止,微觉膝软无力计1分,持续腰酸,劳作加重膝软不任重物计2分,腰酸如折,膝软无力,休息不止,不欲行走计3分;大便正常计0分,大便干结,排便不畅,2日一次计1分,大便躁结,排便不畅,3日一次计2分,大便躁结坚硬,排便艰难,4日以上一次计3分;无夜尿计0分,夜尿1-2次计1分,夜尿3-4次计2分,夜尿5次以上计3分。
2.6 统计方法
3 结果
3.1 两组患者临床疗效对比
表2示,两组治疗后中医证候积分均较治疗前减少(P<0.05或 P<0.01);治疗后两组中医证候积分比较,治疗组低于对照组(P<0.05)。
注:与本组治疗前比较,*P<0.05, **P<0.01;与对照组治疗后比较,ΔP<0.05。
3.3不良反应
治疗组出现1例腹泻,对照组出现1例头痛,1例失眠,症状均较轻微,未停止治疗。治疗组及对照组治疗前后血、尿、便常规, 肝肾功能指标、电解质无变化。
4 讨论
阵发性房颤属于中医心悸这一疾病,其中阴阳两虚,虚阳上浮属十分常见的类型,症见心悸、胸闷、乏力、畏寒肢冷、五心烦热等,使用本发明超微粉水丸取得了不错的疗效。超微粉水丸作为目前中药新剂型,是将中药药材制成直径25~48微米的粉剂,再利用特殊工艺制成丸剂,和汤剂、普通丸剂相比有着明显的优势:1.材料利用率高,节省药材;2.方便携带;3.服用方便,煎煮服即可,可提高患者医从性;4.丸剂煎煮服,较常规服药减少了药物的微生物污染。
温潜法,是一种将阳不在位,浮散在外的元阳纳归原位的治疗方法。温潜法源于仲景的桂枝甘草龙骨牡蛎汤法,最早是由祝味菊提出。祝氏在《伤寒质难》中说:“虚人而躁甚者,气怯于内、阳浮于上也。其为兴奋,乃虚性之兴奋也。宜与温潜法,温以壮其怯,潜以平其逆,引火归源,导龙入海,不可因其外形之兴奋而滥与清滋之药也。”本发明的申请人根据温潜法并结合多年经验总结出本发明超微粉水丸,临床上用于阴阳两虚、虚阳上浮的阵发性房颤病人,取得了非常显著的临床疗效。方中制附子温壮心肾,引火归元;桂枝、桑枝温通经脉,温助阳气;麦冬、地骨皮、鳖甲等滋阴复脉,降火潜阳;牡蛎、磁石、琥珀粉镇心安神、潜阳复脉;炒枣仁,生枣仁合用安神定悸;防己、泽泻、路路通、苏木等除湿活血、通经络;诸药合用以行温通阳气、滋阴复脉、降火潜阳、安神镇静之功。方中附子、桂枝与磁石、牡蛎、鳖甲等配伍温肾潜阳,阴平阳秘,是温潜法的核心体现。
申请人就本发明超微粉水丸合用胺碘酮防治阵发性房颤患者,既减少了患者房颤发作次数,同时还可明显减轻患者症状,提高患者生活质量。本方中多有镇静安神类药物,有研究表明镇静安神的中药对自主神经紊乱性心律失常有较好的疗效 ,安神中药有镇静中枢、调节自主神经作用,可以直接作用于离体或切断神经的心脏,对多种实验性心律失常有显著抑制作用,亦可通过维持交感、迷走神经内分泌稳态,减少肾上腺素异常分泌,增加乙酰胆碱含量,降低自主神经异常对心肌细胞膜离子通道影响。现代药理研究也证实了桂枝、麦冬、葛根可以扩张血管,改善心肌供血,抗血小板聚集;泽泻、路路通、桑枝、通草等利尿、降血压。此外,方中多种药物还具有抗炎、抗氧化、增强免疫、降血脂、抗动脉硬化等作用。由此可见,本发明超微粉水丸具有抗心律失常、改善临床症状及多种保护心血管系统等作用。
房颤作为心血管内科最后无法攻破的堡垒之一,虽然近年来由于对房颤的发生机制的研究的深入,治疗方案已经有了较大的进展,但是由于房颤的高发病率和高致残率,其治疗上仍面临的严峻的挑战。随着中医药在心律失常上的经验的积累,对于房颤是一个十分重要的治疗手段。通过本次的经验总结,本发明的中药组合物对于房颤的疗效确切,在缓解患者症状上更是有独具一格的优势,可以显著提高患者的生活质量。
下面结合具体实施方式对本发明作进一步的说明。
具体实施方式
实施例1:处方:附子6g、桂枝10g、生牡蛎25g、泽泻15g、地骨皮25g、磁石30g、防己20g、路路通20g、炙远志15g、桑白皮20g、苏木 6g、琥珀粉6g、麦冬15g、桑枝10g、葛根15g、通草20g、鳖甲20g、蜣螂 10g、松子12g、生龙骨25g、龟板20g、甘松10g、炒枣仁15g、生枣仁15g、水蛭6g、红花6g、黄连3g、黄芩12g、西洋参 6g、五味子6g、巴戟天7g、银柴胡25g、生地15g。
制备方法:按照以下工艺步骤制得,
(1)将中药材附子、桂枝、生牡蛎、泽泻、地骨皮、磁石、防己、路路通、炙远志、桑白皮、苏木、琥珀粉、麦冬、桑枝、葛根、通草、鳖甲、蜣螂、松子、生龙骨、龟板、甘松、炒枣仁、生枣仁、水蛭、红花、黄连、黄芩、西洋参、五味子、巴戟天、银柴胡、生地,在温度20℃以下利用TY-8L中药超微粉碎机粉碎为超微粉,细度为300目;
(2)将打成超微粉的上述中药材按照处方剂量等比例混合,利用ZWS-Ⅱ型全自动中药水丸机加入处方量3%的辅料淀粉和水,制成水丸即得到超微粉水丸剂。
实施例2:处方:附子5g、桂枝9g、生牡蛎20g、泽泻10g、地骨皮20g、磁石20g、防己10g、路路通10g、炙远志10g、桑白皮10g、苏木5g、琥珀粉5g、麦冬10g、桑枝9g、葛根10g、通草10g、鳖甲10g、蜣螂9g、松子10g、生龙骨10g、龟板10g、甘松9g、炒枣仁10g、生枣仁10g、水蛭5g、红花5g、黄连2g、黄芩10g、西洋参5g、五味子5g、巴戟天6g、银柴胡10g、生地10g。
制备方法:按照以下工艺步骤制得,
(1)将中药材附子、桂枝、生牡蛎、泽泻、地骨皮、磁石、防己、路路通、炙远志、桑白皮、苏木、琥珀粉、麦冬、桑枝、葛根、通草、鳖甲、蜣螂、松子、生龙骨、龟板、甘松、炒枣仁、生枣仁、水蛭、红花、黄连、黄芩、西洋参、五味子、巴戟天、银柴胡、生地,在温度20℃以下利用TY-8L中药超微粉碎机粉碎为超微粉,细度为250目;
(2)将打成超微粉的上述中药材按照处方剂量等比例混合,利用ZWS-Ⅱ型全自动中药水丸机加入处方量1%的辅料淀粉和水,制成水丸即得到超微粉水丸剂。
实施例3:处方:附子7g、桂枝11g、生牡蛎30g、泽泻20g、地骨皮30g、磁石40g、防己30g、路路通30g、炙远志20g、桑白皮30g、苏木7g、琥珀粉7g、麦冬20g、桑枝11g、葛根20g、通草30g、鳖甲30g、蜣螂11g、松子15g、生龙骨30g、龟板30g、甘松11g、炒枣仁20g、生枣仁20g、水蛭7g、红花7g、黄连4g、黄芩15g、西洋参7g、五味子7g、巴戟天8g、银柴胡30g、生地20g。
制备方法:按照以下工艺步骤制得,
(1)将中药材附子、桂枝、生牡蛎、泽泻、地骨皮、磁石、防己、路路通、炙远志、桑白皮、苏木、琥珀粉、麦冬、桑枝、葛根、通草、鳖甲、蜣螂、松子、生龙骨、龟板、甘松、炒枣仁、生枣仁、水蛭、红花、黄连、黄芩、西洋参、五味子、巴戟天、银柴胡、生地,在温度20℃以下利用TY-8L中药超微粉碎机粉碎为超微粉,细度为350目;
(2)将打成超微粉的上述中药材按照处方剂量等比例混合,利用ZWS-Ⅱ型全自动中药水丸机加入处方量5%的辅料淀粉和水,制成水丸即得到超微粉水丸剂。
Claims (4)
1.一种防治阵发性房颤的中药组合物,其特征在于:由以下重量份的原料药制成超微粉水丸剂:附子5-7份、桂枝9-11份、生牡蛎20-30份、泽泻10-20份、地骨皮20-30份、磁石20-40份、防己10-30份、路路通10-30份、炙远志10-20份、桑白皮10-30份、苏木5-7份、琥珀粉5-7份、麦冬10-20份、桑枝9-11份、葛根10-20份、通草10-30份、鳖甲10-30份、蜣螂9-11份、松子10-15份、生龙骨10-30份、龟板10-30份、甘松9-11份、炒枣仁10-20份、生枣仁 10-20份、水蛭5-7份、红花5-7份、黄连2-4份、黄芩10-15份、西洋参5-7份、五味子5-7份、巴戟天6-8份、银柴胡10-30份、生地10-20份。
2.根据权利要求1所述的防治阵发性房颤的中药组合物,其特征在于:所述原料的重量为:附子6g、桂枝10g、生牡蛎25g、泽泻15g、地骨皮25g、磁石30g、防己20g、路路通20g、炙远志15g、桑白皮20g、苏木 6g、琥珀粉6g、麦冬15g、桑枝10g、葛根15g、通草20g、鳖甲20g、蜣螂10g、松子12g、生龙骨25g、龟板20g、甘松10g、炒枣仁15g、生枣仁 15g、水蛭6g、红花6g、黄连3g、黄芩12g、西洋参 6g、五味子6g、巴戟天7g、银柴胡25g、生地15g。
3.权利要求1或2所述的中药组合物制备的超微粉水丸剂,其特征在于:按照以下工艺步骤制得,
(1)将中药材附子、桂枝、生牡蛎、泽泻、地骨皮、磁石、防己、路路通、炙远志、桑白皮、苏木、琥珀粉、麦冬、桑枝、葛根、通草、鳖甲、蜣螂、松子、生龙骨、龟板、甘松、炒枣仁、生枣仁、水蛭、红花、黄连、黄芩、西洋参、五味子、巴戟天、银柴胡、生地,在温度20℃以下用中药超微粉碎机粉碎为超微粉,细度为250-350目;
(2)将打成超微粉的上述中药材按照处方剂量混合,利用全自动中药水丸机加入处方量1%-5%的辅料淀粉和水,制成水丸,即得到超微粉水丸剂。
4.如权利要求3所述的超微粉水丸剂在制备防治阵发性房颤药物中的应用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810822906.XA CN108938912B (zh) | 2018-07-25 | 2018-07-25 | 防治阵发性房颤的中药组合物及其超微粉水丸剂和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810822906.XA CN108938912B (zh) | 2018-07-25 | 2018-07-25 | 防治阵发性房颤的中药组合物及其超微粉水丸剂和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108938912A CN108938912A (zh) | 2018-12-07 |
CN108938912B true CN108938912B (zh) | 2021-05-04 |
Family
ID=64464709
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810822906.XA Active CN108938912B (zh) | 2018-07-25 | 2018-07-25 | 防治阵发性房颤的中药组合物及其超微粉水丸剂和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108938912B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115400188B (zh) * | 2022-08-17 | 2023-07-04 | 上海中医药大学附属曙光医院 | 一种治疗房颤的中药组合物 |
-
2018
- 2018-07-25 CN CN201810822906.XA patent/CN108938912B/zh active Active
Non-Patent Citations (1)
Title |
---|
温潜复律超微粉水丸合用胺碘酮治疗阵发性房颤的临床观察;姚天阳等;《医师在线》;20170818(第8期);正文讨论部分第2段 * |
Also Published As
Publication number | Publication date |
---|---|
CN108938912A (zh) | 2018-12-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101011561B (zh) | 黄连温胆汤现代中药口服制剂及其生产方法 | |
CN101485830B (zh) | 一种中药抗衰老保健胶囊 | |
CN103520572A (zh) | 一种用于治疗特应性皮炎的中药组合物及其制备方法 | |
CN108938912B (zh) | 防治阵发性房颤的中药组合物及其超微粉水丸剂和应用 | |
CN112870286B (zh) | 治疗特应性皮炎的中药组合物、制备方法及其应用 | |
CN112316051B (zh) | 养血化痰中药组合物及其中药制剂、制备方法和应用 | |
CN102302633B (zh) | 一种治疗妇女血崩的中药组合物及其制备方法 | |
CN103800789A (zh) | 一种健脾补肾的中药组合物及其制备方法 | |
TWI721367B (zh) | 調節內分泌、提高免疫力、延緩衰老以及預防或治療便秘的組合物、其應用及其製備方法 | |
CN102327406B (zh) | 一种利尿的中药组合物及其制备方法和应用 | |
CN102274357B (zh) | 一种治疗冠状动脉硬化性心脏病的药物组合物及其制备方法 | |
CN106309870A (zh) | 一种具有安神助眠作用的中药组合物 | |
CN104800600A (zh) | 一种治疗高血压的药物 | |
CN104352866A (zh) | 一种治疗火毒伤津型烧伤的中药制剂及其制备方法 | |
CN113679781B (zh) | 一种治疗快速性心律失常的中药组合物及其制备方法和应用 | |
CN102824446B (zh) | 一种具有抗疲劳作用的药物组合物及其制备方法与应用 | |
CN104435153A (zh) | 一种治疗高血压的中药组合物及制法 | |
Fu et al. | Effects of Dingjifumai Decoction on Electrocardiogram and sodium potassium pump of rats with ventricular arrhythmia | |
CN105381204A (zh) | 一种百草之王长寿药剂及其制备方法 | |
CN104706942A (zh) | 一种治疗脑心综合征的药物组合物及其制备方法 | |
CN105477550A (zh) | 一种治疗更年期抑郁症的中药制剂及其制备方法 | |
CN105327140A (zh) | 一种养护心脏的中药制剂 | |
CN104367650A (zh) | 慢性痢疾活血止痢制剂及制备方法 | |
CN118286350A (zh) | 一种用于治疗高脂血症、高血压病的中药及其应用 | |
CN104524423A (zh) | 一种治疗肝郁脾虚型心肌梗死后抑郁症的中药及制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |